Diabetic retinopathy (DR) is a common chronic complication of diabetes mellitus. Endothelin-1 (ET-1) has been identified as a key regulator of various ocular functions, including vascular perfusion, ...

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

Quadrant-specific changes in superficial vascular complex vessel density, particularly in the 16- to 21-mm temporal region, are potential early biomarkers for diabetic retinopathy. Widefield ...

In research published in the journal Gut, investigators from the University of Alabama at Birmingham report that restoring tryptophan metabolism in the gut microbiome can prevent or reverse diabetic ...

A higher incidence of new diabetic retinopathy has previously been reported in patients using GLP-1 receptor agonists. A new retrospective study suggested that use of tirzepatide was tied to a reduced ...

Diabetic retinopathy (DR), a leading cause of vision impairment among working-age adults, affects approximately 146 million individuals globally, with projections estimating an increase to 180 million ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. The “#SeeBeyondSugar” campaign, which began rolling out amid Nov. 14’s World ...

Ensemble deep-learning system with xAI (Grad-CAM) for automated diabetic retinopathy detection and staging using retinal fundus images.

A reduction in the foveal avascular zone area may be the earliest structural change in the retina of patients with diabetic retinopathy. Both central macular thickness (CMT) and foveal avascular zone ...